Yeah, Trump threats (veiled?) are going to be a big test for mid-large cap pharma companies. Reluctant to to invest in big companies until things resolve a bit more.
I got into QCOR in 2000, so that was $1 and change. Only sold a tiny bit to ride free shares way back then.
I'm still looking at small-cap pharma, emphasis on orphan drugs and companies with a good amount of reserve cash.
News 
Market Data 
Discover 
